Emine Cil (E Cil)

Publication Activity (10 Years)

Years Active: 2021-2022
Publications (10 Years): 7

Top Topics

Coronavirus Disease

Signaling Pathway

Pseudomonas Aeruginosa

Top Venues

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Efstathios S Giotis, Emine Cil, Greg N Brooke
Use of Antiandrogens as Therapeutic Agents in COVID-19 Patients. Viruses 14 (12) (2022)
Efstathios S Giotis, Emine Cil, Greg N Brooke
Use of Antiandrogens as Therapeutic Agents in COVID-19 Patients. Viruses 14 (12) (2022)
Efstathios S Giotis, Emine Cil, Greg N Brooke
Use of Antiandrogens as Therapeutic Agents in COVID-19 Patients. Viruses 14 (12) (2022)
Efstathios S Giotis, Emine Cil, Greg N Brooke
Use of Antiandrogens as Therapeutic Agents in COVID-19 Patients. Viruses 14 (12) (2022)
Efstathios S Giotis, Emine Cil, Greg N Brooke
Use of Antiandrogens as Therapeutic Agents in COVID-19 Patients. Viruses 14 (12) (2022)
Efstathios S Giotis, Emine Cil, Greg N Brooke
Use of Antiandrogens as Therapeutic Agents in COVID-19 Patients. Viruses 14 (12) (2022)
D A Leach, A Mohr, Efstathios S Giotis, Emine Cil, A M Isac, L L Yates, Wendy S Barclay, R M Zwacka, Charlotte Lynne Bevan, Greg N Brooke
The antiandrogen enzalutamide downregulates TMPRSS2 and reduces cellular entry of SARS-CoV-2 in human lung cells. Nature communications 12 (1) (2021)